Subcutaneous Versus Combined Subcutaneous and Intramuscular Botulinum Toxin for Androgenetic Alopecia: A Randomized Clinical Trial

This publication has 17 references indexed in Scilit:

• Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial
  Archives of Dermatological Research, 2024
• Efficacy of botulinum toxin in male androgenetic alopecia: A triple-blind, randomized clinical trial
  Journal of the American Academy of Dermatology, 2024
• Androgenetic alopecia: Update on etiology
  Dermatological Reviews, 2021
• The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism
  Journal of the American Academy of Dermatology, 2020
• Finasteride and androgenic alopecia; from therapeutic options to medical implications
  Journal of Dermatological Treatment, 2019
• The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis
  Journal of the American Academy of Dermatology, 2017
• Androgenetic Alopecia: An Update of Treatment Options
  Drugs, 2016
• Treatment of Male Pattern Baldness with Botulinum Toxin: A Pilot Study
  Plastic and Reconstructive Surgery, 2010
• Effect of Botulinum Toxin Type A on Transforming Growth Factor β1 in Fibroblasts Derived from Hypertrophic Scar: A Preliminary Report
  Aesthetic Plastic Surgery, 2009
• Transcutaneous Po2 of the Scalp in Male Pattern Baldness: A New Piece to the Puzzle
  Plastic and Reconstructive Surgery, 1996